To bleed or not to bleed? Is that the question for the PTT?

Area of Science:

• Hematology
• Clinical Diagnostics

Background:

• The activated partial thromboplastin time (PTT) test evolved from the Lee-White whole blood clot time (WBCT).
• Both tests were initially developed for diagnosing hemophilia in patients with a high pretest probability of bleeding.

Observation:

• Current medical practice predominantly uses PTT for routine admission orders, representing a low pretest probability scenario.
• The clinical question addressed by the PTT has shifted from 'why does this patient bleed?' to 'will this patient bleed?'

Findings:

• The PTT was not originally designed to predict future bleeding events.
• Elevated PTT results are not strongly predictive of hemorrhage.
• Normal PTT results do not exclude the risk of bleeding.

Implications:

• Interpretation of PTT results requires careful consideration of the evolving clinical context and limitations.
• The PTT's utility in predicting bleeding risk in low-probability populations is questionable.
• Clinical decisions regarding hemorrhage risk should not solely rely on PTT values.